AH — Aleafia Health Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- CA$8.06m
- CA$53.87m
- CA$42.85m
Annual income statement for Aleafia Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 15 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.33 | 16.4 | 44.5 | 43.1 | 42.8 |
| Cost of Revenue | |||||
| Gross Profit | 2.79 | 20.8 | -5.61 | -11.9 | 6 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 23.1 | 45.5 | 292 | 202 | 67.1 |
| Operating Profit | -19.8 | -29.2 | -247 | -159 | -24.2 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.5 | -36.6 | -250 | -173 | -34.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -18.5 | -39.6 | -247 | -170 | -34.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -18.5 | -39.6 | -247 | -170 | -34.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -18.5 | -39.6 | -247 | -170 | -34.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.159 | -0.168 | -0.403 | -0.358 | -0.074 |
| Dividends per Share |